Version 1
: Received: 28 October 2020 / Approved: 29 October 2020 / Online: 29 October 2020 (15:38:54 CET)
How to cite:
Farahinia, A.; Zhang, W.; Badea, I. Circulating Tumor Cell Separation of Blood Cells and Sorting in novel Microfluidic approaches: a review. Preprints2020, 2020100622. https://doi.org/10.20944/preprints202010.0622.v1
Farahinia, A.; Zhang, W.; Badea, I. Circulating Tumor Cell Separation of Blood Cells and Sorting in novel Microfluidic approaches: a review. Preprints 2020, 2020100622. https://doi.org/10.20944/preprints202010.0622.v1
Farahinia, A.; Zhang, W.; Badea, I. Circulating Tumor Cell Separation of Blood Cells and Sorting in novel Microfluidic approaches: a review. Preprints2020, 2020100622. https://doi.org/10.20944/preprints202010.0622.v1
APA Style
Farahinia, A., Zhang, W., & Badea, I. (2020). Circulating Tumor Cell Separation of Blood Cells and Sorting in novel Microfluidic approaches: a review. Preprints. https://doi.org/10.20944/preprints202010.0622.v1
Chicago/Turabian Style
Farahinia, A., W.J. Zhang and Ildiko Badea. 2020 "Circulating Tumor Cell Separation of Blood Cells and Sorting in novel Microfluidic approaches: a review" Preprints. https://doi.org/10.20944/preprints202010.0622.v1
Abstract
Separation and interpretation of rebellious Circulating Tumor Cells (CTCs) originating from the primary tumor or cancer tissue plays a significant role in diagnostics, cancer progression analyses, suitable medicine exploration, and treatment proficiency examination. Cancer metastasis occurs when CTCs spread throughout the body and invade healthy tissues, leading to new tumors in that area. Although a dramatic rate of deaths begins from spreading CTCs around the body, valuable measures have been made to control their development. However, the first step is separating these harmful cells from the bloodstream and investigating their features. Having examined the characteristics of CTCs as cancer’s main strength, researchers can introduce complementary treatments that can affect cancerous cells without damaging the healthy cells. Therefore, according to their unique characteristics, numerous techniques have been established for continuous and fast separation and sorting of CTCs. Nevertheless, few separators enjoy the efficient performance and appropriate accuracy and can be produced in mass numbers due to the available fabrication equipment. Microfabrication advancements enable separators to combine the advantages of active and passive methods in a small-scale platform for probing individual cells and separation purposes. Reduction in reagents, sample volume, analysis time, and less harmfulness to patients are some of the motivations that encourage researchers to employ microfluidic instruments for CTCs separation from other blood cells over the last two decades. However, microfabrication limitations mean effective separators, and the diagnostic option they provide, are not readily available. Addressing these limitations requires optimizing the design and fabrication of separators such that they are reduced in their size and fabrication cost, while also maintaining high-throughput separating capability. The emergence of the Lab-On-a-Chip (LOC) and then Lab-On-a-CD (LOCD) technologies, having more inherent benefits than conventional microfluidic devices, has created new opportunities and become increasingly widespread in recent years. Evidence suggests that employing single methodologies or integrating approaches without sufficient understanding of potential outcomes is unlikely to result in successful diagnostic results. This paper contributes an extensive review of several separation systems, including fundamental theories and experimental details, and describes detailed operating principles and device performance.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
